Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
CRYSTALLINE FORMS OF A BIPHENYL COMPOUND

No-Receipt date 2010-00548 - 18/02/2010
No-Filing date 20100400384 - 18/02/2010
No-Granting date 3071292 - 18/02/2010
No-EPO application date 06737787.9 - 09/03/2006
No-EPO granting date 1856050 - 25/11/2009
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 2/2010 - 22/03/2010
Expiration date 10/03/2026
Kind of title Validation of European Patent
Legal status VALID
Priorities US660208 P10/03/2005/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/45
A61P 11/06
C07D 211/46

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
653451 THERAVANCE BIOPHARMA R&D IP, LLC 901 GATEWAY BOULEVARDSOUTH SAN FRANCISCO, CA 94080 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
723416 AXT, SABINE
723417 CHURCH, TIMOTHY J.
723418 MALATHONG, VIENGKHAM

Representatives
CodeFirstnameSurnameAddressTownZip
1815ATHANASIOSTSIMIKALISN. VAMVA 1ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
5368ATHANASIOSTSIMIKALISN. VAMVA 1ATHINA (ATTIKIS)10674 GREECE

Owners History
Date Description Comments Data before modification Data after modification
06/11/2015 Μεταβίβαση (7e802) ΑΡ.ΠΡΩΤ. 5560/8-10-2015, ΚΩΔ.ΠΛΗΡ. 3089 307255 Theravance, Inc. 901 Gateway Boulevard ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ South San Francisco, CA 94080 653451 Theravance Biopharma R&D IP, LLC 901 Gateway Boulevard ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ South San Francisco, CA 94080

Title Instruments

Payments history 20 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).